NASDAQ:AZRX
Delisted
AzurRx BioPharma Inc Stock News
$0.155
-0.0080 (-4.90%)
At Close: Aug 17, 2022
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) * Allovir Inc (NASDAQ: ALVR) * Erytech Pharma SA (NASDAQ: ERYP) * Eyenovia Inc (NASDAQ: EYEN) (announced an exclusive collaboration
* Data from first five patients demonstrate positive results with primary efficacy and secondary safety endpoints achieved * Clinically meaningful improvement (>80%) in coefficient of fat absorption
LD Micro Announces Preliminary List of Presenters for the LD-500.
03:04pm, Wednesday, 05'th Aug 2020
LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively onlin
AZRX: Capital Raise, OPTION 2 Trial Underway
09:22am, Monday, 27'th Jul 2020
By John Vandermosten, CFA NASDAQ:AZRX On July 20, 2020, AzurRx (NASDAQ: AZRX) announced the closing of $15.2 million in a private placement and repayment of $6.9 million in convertible notes. The proc
Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors o
* Three OPTION 2 clinical trial sites activated in the U.S. * Topline data expected in Q1 2021NEW YORK, July 22, 2020 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX) (“AzurRx” or the “
Alexander Capital, L.P. Congratulates AzurRx BioPharma on $15.2 Million Private Placement and $6.9 Million Convertible Note Exchange
12:00pm, Tuesday, 21'st Jul 2020
New York, NY, July 21, 2020 -- Private placement resulting in gross cash proceeds of $15.2 million to advance two Phase 2 clinical trials of MS1819 in patients with cystic.
AzurRx BioPharma Closes $15.2 Million Private Placement and $6.9 Million Convertible Note Exchange
12:00pm, Monday, 20'th Jul 2020
Private placement resulting in gross cash proceeds of $15.2 million to advance two Phase 2 clinical trials of MS1819 in patients with cystic fibrosisExchange of $6.9 million.
Global Antimicrobial Coatings Market (2020 to 2025) - Drivers, Constraints and Challenges - ResearchAndMarkets.com
12:00am, Wednesday, 24'th Jun 2020
The
COVID-19 Diagnostic Kits and Therapy Market to Reach $13.9 Billion by 2025- Exclusive Report by Meticulous Research®
04:58pm, Friday, 19'th Jun 2020
According to a new market research report “COVID-19 Diagnostics (PCR Testing, Antibody Testing) and Therapy (Immunotherapy, Vaccines, Antiviral, Cell-based,
A Blue Ocean Robotics bejelentette, hogy a vállalatot UVD robotjai sikerének elismeréseként a Robotics Business Review szaklap belefoglalta abba a lis
Blue Ocean Robotics and its UVD Robots Recognized as Top 50 Most Influential Robotics Company by Robotics Business Review
01:02pm, Monday, 15'th Jun 2020
Experiences Continued Global Growth as Disinfecting Robot Is Used as Effective Weapon Against Coronavirus and Hospital-Acquired InfectionsODENSE, Denmark — Blue Ocean Robotics announced it ha…
Blue Ocean Robotics and its UVD Robots Recognized as Top 50 Most Influential Robotics Company by Robotics Business Review
11:02am, Monday, 15'th Jun 2020
Blue Ocean Robotics announced it has been included in Robotics Business Review’s list of the 50 most influential robotics companies in the world (RBR50) for its UVD Robots.
Blue Ocean Robotics and its UVD Robots Recognized as Top 50 Most Influential Robotics Company by Robotics Business Review
12:00am, Monday, 15'th Jun 2020
Blue Ocean Robotics' UVD Robots acknowledged as weapon against coronavirus in Robotics Business Review's new Top 50 of innovative robotics companies.
AZRX: Next Up: OPTION 2
09:45am, Monday, 01'st Jun 2020
By John Vandermosten, CFA NASDAQ:AZRX READ THE FULL AZRX RESEARCH REPORT On May 15th, 2020, AzurRx BioPharma, Inc. (NASDAQ:AZRX) filed its first quarter 2020 10-Q with the SEC for the three month peri
